NCT04053712View on ClinicalTrials.gov

Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 16, 2019

Primary Completion Date

March 19, 2021

Study Completion Date

March 19, 2021

Conditions
Type 1 DiabetesHypoglycemia
Interventions
DRUG

Glucagon

GlucaGen(R), Novo Nordisk, DK

DEVICE

Closed-loop system

Closed-loop system comprise of two DANA RS (R) insulin pumps (FiAsp-GlucaGen vs FiAsp-saline), one DexCom G6 sensor, and a smartphone for the control algorithm.

Trial Locations (1)

Unknown

Steno Diabetes Center Copenhagen, Gentofte Municipality

All Listed Sponsors
collaborator

Technical University of Denmark

OTHER

collaborator

University of Copenhagen

OTHER

collaborator

Danish Diabetes Academy

OTHER

lead

Steno Diabetes Center Copenhagen

OTHER

NCT04053712 - Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes | Biotech Hunter | Biotech Hunter